BerandaCONCORDBIO • NSE
add
Concord Biotech Ltd
Tutup sebelumnya
₹1.750,20
Rentang hari
₹1.735,00 - ₹1.763,80
Rentang tahun
₹1.345,00 - ₹2.664,00
Kapitalisasi pasar
182,12Â M INR
Volume Rata-Rata
268,53Â rb
Rasio P/E
48,90
Hasil dividen
-
Bursa utama
NSE
Berita pasar
.INX
0,83%
0,77%
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(INR) | Mar 2025info | Perubahan Y/Y |
---|---|---|
Pendapatan | 4,30Â M | 34,77% |
Biaya operasional | 962,43Â jt | 13,00% |
Laba bersih | 1,40Â M | 47,75% |
Margin laba bersih | 32,66 | 9,63% |
Penghasilan per saham | 13,42 | 47,80% |
EBITDA | 1,89Â M | 33,07% |
Tarif pajak efektif | 23,51% | — |
Neraca
Total aset
Total liabilitas
(INR) | Mar 2025info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 3,18Â M | 12,80% |
Total aset | 20,34Â M | 19,61% |
Total liabilitas | 2,22Â M | 27,27% |
Total ekuitas | 18,13 M | — |
Saham yang beredar | 104,61 jt | — |
Harga terhadap nilai buku | 10,10 | — |
Tingkat pengembalian aset | — | — |
Tingkat pengembalian modal | 25,78% | — |
Arus Kas
Perubahan kas bersih
(INR) | Mar 2025info | Perubahan Y/Y |
---|---|---|
Laba bersih | 1,40Â M | 47,75% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Concord Biotech Limited is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients sold worldwide.
It manufactures biopharmaceutical products across therapy segments such as immunosuppressant, oncology, antifungal, antibacterial and anthelmintic. It has two manufacturing facilities–at Dholka near Ahmedabad, which is approved by USFDA, and at Limbasi in Kheda district. Wikipedia
Didirikan
2000
Situs
Karyawan
1.377